Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Anemia

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 43 articles: HTML format

Single Articles

October 2026
1. ESSA M, Algeri M, Alzahrani M, Bernaudin F, et al
   Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee.
   Bone Marrow Transplant. 2026;61:1379-1387.
   PubMed     Abstract available
   
   
   
2. DE FRANCESCHI L, Aljurf M, Baronciani D, Bento C, et al
   Update of the decision-making algorithm on selecting transfusion-dependent beta-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party.
   Bone Marrow Transplant. 2026;61:1316-1326.
   PubMed     Abstract available
   
   
   August 2026
3. DROZD-SOKOLOWSKA J, Gilbert P, Tuffnell J, Koster L, et al
   Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.
   Bone Marrow Transplant. 2026 Aug 13. doi: 10.1038/s41409-026-03007.
   PubMed    
   
   
   July 2026
4. ELGOHARY G, Alsharif M, El Fakih R, Mohammed Ben Lamine C, et al
   Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.
   Bone Marrow Transplant. 2026 Jul 22. doi: 10.1038/s41409-026-02982.
   PubMed     Abstract available
   
   
   
5. LIN F, Han T, He Y, Xu Z, et al
   Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.
   Bone Marrow Transplant. 2026 Jul 3. doi: 10.1038/s41409-026-02959.
   PubMed    
   
   
   
6. ALASBALI R, Alzahrani M, Wilkerson K, Akhom P, et al
   Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease.
   Bone Marrow Transplant. 2026;61:847-851.
   PubMed     Abstract available
   
   
   June 2026
7. NIRMAL G, Chadha V, Verma S, Baby EP, et al
   Safety, efficacy and feasibility of GCSF and plerixafor based CD34 mobilization for backup autologous stem cell collection in patients undergoing alternate donor hematopoietic stem cell transplant for sickle cell disease: Take away lessons for gene th
   Bone Marrow Transplant. 2026 Jun 24. doi: 10.1038/s41409-026-02948.
   PubMed     Abstract available
   
   
   May 2026
8. HE W, Han T, He Y, Zhang Y, et al
   Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis.
   Bone Marrow Transplant. 2026 May 20. doi: 10.1038/s41409-026-02904.
   PubMed    
   
   
   
9. PETIT AF, Sterin A, Gandemer V, Goudet C, et al
   Upfront alemtuzumab-based MUD HSCT in childhood aplastic anemia: excellent survival and GRFS, but immune challenges persist.
   Bone Marrow Transplant. 2026 May 11. doi: 10.1038/s41409-026-02868.
   PubMed    
   
   
   April 2026
10. LIN MH, Gao SN, Huang XJ, Xu LP, et al
    Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes.
    Bone Marrow Transplant. 2026 Apr 13. doi: 10.1038/s41409-026-02855.
    PubMed     Abstract available
    
    
    
11. VOLT F, Akhoudas M, Kenzey C, Cappelli B, et al
    Umbilical cord blood transplantation in children with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2026 Apr 9. doi: 10.1038/s41409-026-02852.
    PubMed     Abstract available
    
    
    December 2025
12. GIAMMARCO S, Bacigalupo A, Mordini N, Zallio F, et al
    Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis.
    Bone Marrow Transplant. 2025 Dec 2. doi: 10.1038/s41409-025-02750.
    PubMed    
    
    
    
13. CACACE F, Dicks MJ, Siliceo P
    Insights in bone marrow failure syndromes: take home messages from the 3rd ESH-EBMT-EHA-IPIG translational research conference.
    Bone Marrow Transplant. 2025;60:1551-1558.
    PubMed     Abstract available
    
    
    November 2025
14. LI ZF, Xiong H, Chen Z, Yang L, et al
    Author response: comparative efficacy of HSCT strategies in pediatric aplastic anemia.
    Bone Marrow Transplant. 2025 Nov 10. doi: 10.1038/s41409-025-02741.
    PubMed    
    
    
    June 2025
15. JING Z, Zhao L, Mai Y, Sun P, et al
    Hematopoietic stem cell transplantation outcomes in pediatric acquired aplastic anemia with inherited bone marrow failure syndrome-associated genes.
    Bone Marrow Transplant. 2025 Jun 25. doi: 10.1038/s41409-025-02671.
    PubMed    
    
    
    
16. ZHAO X, Zhang YP, Ye BD, Lu PH, et al
    Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40-50: a retrospective analysis from the CBMTR over the past decade.
    Bone Marrow Transplant. 2025 Jun 17. doi: 10.1038/s41409-025-02617.
    PubMed    
    
    
    May 2025
17. MONTORO J, Eikema DJ, Piepenbroek B, Tuffnell J, et al
    Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT.
    Bone Marrow Transplant. 2025 May 27. doi: 10.1038/s41409-025-02633.
    PubMed     Abstract available
    
    
    
18. LIMERICK E, Hsieh MM, Barretto M, Jeffries N, et al
    Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease.
    Bone Marrow Transplant. 2025;60:690-696.
    PubMed     Abstract available
    
    
    April 2025
19. IBRAHIMOVA A, Khoury R, Jodele S, Grimley M, et al
    Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2025 Apr 29. doi: 10.1038/s41409-025-02601.
    PubMed     Abstract available
    
    
    
20. GONZALEZ VICENT M, Pereto A, Zubicaray J, Molina B, et al
    Outcomes in allogeneic hematopoietic stem cell transplantation for Fanconi anemia.
    Bone Marrow Transplant. 2025 Apr 12. doi: 10.1038/s41409-025-02591.
    PubMed    
    
    
    
21. LIU J, Mai Y, Jing Z, Zhao L, et al
    Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children.
    Bone Marrow Transplant. 2025 Apr 6. doi: 10.1038/s41409-025-02577.
    PubMed     Abstract available
    
    
    March 2025
22. KLEINSCHMIDT K, Penkivech G, Troeger A, Foell J, et al
    alphass T-cell depleted haploidentical stem cell transplantation for pediatric and young adult patients with transfusion-dependent thalassemia.
    Bone Marrow Transplant. 2025 Mar 18. doi: 10.1038/s41409-025-02546.
    PubMed     Abstract available
    
    
    February 2025
23. LIN MH, Huang XJ, Xu LP, Wang Y, et al
    The haematopoietic cell transplantation comorbidity index predicts clinical outcomes for severe aplastic anaemia patients after haploidentical haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2025 Feb 13. doi: 10.1038/s41409-025-02513.
    PubMed     Abstract available
    
    
    November 2024
24. GIAMMARCO S, Limongiello MA, Di Marino L, Metafuni E, et al
    The role of daratumumab in complications post-allogeneic hematopoietic stem cell transplantation: a single-center prospective study on PRCA and AIHA.
    Bone Marrow Transplant. 2024 Nov 20. doi: 10.1038/s41409-024-02479.
    PubMed     Abstract available
    
    
    September 2024
25. URIA-OFICIALDEGUI ML, Quintero V, Benitez-Carabante MI, Bueno D, et al
    Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood.
    Bone Marrow Transplant. 2024 Sep 3. doi: 10.1038/s41409-024-02406.
    PubMed    
    
    
    August 2024
26. LIU L, Han B, Zhang Y, Lei M, et al
    First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.
    Bone Marrow Transplant. 2024 Aug 1. doi: 10.1038/s41409-024-02377.
    PubMed     Abstract available
    
    
    June 2024
27. GILMORE RM, Abernathy K, Shultes K, Eplin DD, et al
    Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
    Bone Marrow Transplant. 2024 Jun 15. doi: 10.1038/s41409-024-02323.
    PubMed     Abstract available
    
    
    
28. LONGVAL T, Lepretre AC, Ravinet A, Fayard A, et al
    Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
    Bone Marrow Transplant. 2024;59:893-895.
    PubMed    
    
    
    May 2024
29. VASSEUR L, Cuffel A, Pondarre C, Dalle JH, et al
    Early lymphocyte reconstitution and viral infections in adolescents and adults transplanted for sickle cell disease.
    Bone Marrow Transplant. 2024;59:708-710.
    PubMed    
    
    
    April 2024
30. ZHANG X, Zhao X, Chen S, Hao M, et al
    Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients.
    Bone Marrow Transplant. 2024 Apr 5. doi: 10.1038/s41409-024-02266.
    PubMed     Abstract available
    
    
    
31. CIANGOLA G, Santinelli E, McLornan DP, Pagliuca S, et al
    Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond?
    Bone Marrow Transplant. 2024;59:444-450.
    PubMed     Abstract available
    
    
    March 2024
32. FURST S, Bernit E, Legrand F, Granata A, et al
    Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
    Bone Marrow Transplant. 2024 Mar 14. doi: 10.1038/s41409-024-02257.
    PubMed     Abstract available
    
    
    
33. JO T, Arai Y, Kitawaki T, Nakamura N, et al
    KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis.
    Bone Marrow Transplant. 2024;59:419-421.
    PubMed    
    
    
    February 2024
34. YAMAMOTO R, Hiramoto N, Fujimoto A, Yamazaki H, et al
    Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2024 Feb 10. doi: 10.1038/s41409-024-02234.
    PubMed    
    
    
    
35. MEISSNER B, Lang P, Bader P, Hoenig M, et al
    Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.
    Bone Marrow Transplant. 2024 Feb 7. doi: 10.1038/s41409-024-02219.
    PubMed     Abstract available
    
    
    January 2024
36. GREENMYER JR, Ariagno S, Ali A, Pence L, et al
    Autoimmune cytopenias following pediatric hematopoietic cell transplant.
    Bone Marrow Transplant. 2024;59:117-120.
    PubMed    
    
    
    December 2023
37. GABELLI M, Perez-Martinez A, Bueno Sanchez D, Lucchini G, et al
    Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2023 Dec 14. doi: 10.1038/s41409-023-02173.
    PubMed    
    
    
    October 2023
38. AYAS M, Al-Hashim F, Siddiqui K, Al-Jefri A, et al
    Hematopoietic stem cell transplantation in patients with Fanconi anemia: a report of late effects and psychosocial adjustment in life.
    Bone Marrow Transplant. 2023 Oct 25. doi: 10.1038/s41409-023-02133.
    PubMed    
    
    
    
39. CANCIO M, Troullioud Lucas AG, Bierings M, Klein E, et al
    Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia.
    Bone Marrow Transplant. 2023 Oct 17. doi: 10.1038/s41409-023-02121.
    PubMed     Abstract available
    
    
    September 2023
40. SATTY AM, Klein E, Mauguen A, Kunvarjee B, et al
    T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
    Bone Marrow Transplant. 2023 Sep 29. doi: 10.1038/s41409-023-02113.
    PubMed     Abstract available
    
    
    August 2023
41. ROSSI M, Szepetowski S, Yakouben K, Paillard C, et al
    Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of St
    Bone Marrow Transplant. 2023 Aug 4. doi: 10.1038/s41409-023-02079.
    PubMed    
    
    
    July 2023
42. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.
    Bone Marrow Transplant. 2023;58:832-834.
    PubMed    
    
    
    April 2023
43. GOMEZ-ARTEAGA A, Orfali N, Pasciolla M, Baptiste A, et al
    Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
    Bone Marrow Transplant. 2023 Apr 12. doi: 10.1038/s41409-023-01981.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum